Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
Tabár, L. et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 260, 658–663 (2011).
Marmot, M. G. et al. The benefits and harms of breast cancer screening: an independent review. Lancet 380, 1778–1786 (2012).
Miller-Kleinhenz, J. M. et al. Racial disparities in diagnostic delay among women with breast cancer. J. Am. Coll. Radiol. 18, 1384–1393 (2021).
Ng, A. Y. et al. Prospective implementation of AI-assisted screen reading to improve early detection of breast cancer. Nat. Med. 29, 3044–3049 (2023).
Eisemann, N. et al. Nationwide real-world implementation of AI for cancer detection in population-based mammography screening. Nat. Med. 31, 917–924 (2025).
Hernström, V. et al. Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study. Lancet Digit. Health 7, e175–e183 (2025).
Salim, M. et al. AI-based selection of individuals for supplemental MRI in population-based breast cancer screening: the randomized ScreenTrustMRI trial. Nat. Med. 30, 2623–2630 (2024).
Lauritzen, A. D. et al. Early indicators of the impact of using AI in mammography screening for breast cancer. Radiology 311, e232479 (2024).
Dembrower, K., Crippa, A., Colón, E., Eklund, M. & Strand, F. Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study. Lancet Digit. Health 5, E703–E711 (2023).
Oberije, C. J. G. et al. Assessing artificial intelligence in breast screening with stratified results on 306 839 mammograms across geographic regions, age, breast density and ethnicity: A Retrospective Investigation Evaluating Screening (ARIES) study. BMJ Health Care Inform. 32, e101318 (2025).
Logan, J., Kennedy, P. J. & Catchpoole, D. A review of the machine learning datasets in mammography, their adherence to the FAIR principles and the outlook for the future. Sci. Data 10, 595 (2023).
Centers for Devices and Radiological Health MQSA national statistics. FDA https://www.fda.gov/radiation-emitting-products/mammography-information-patients/mqsa-national-statistics (2025).
Kim, J. G. et al. Impact of a categorical AI system for digital breast tomosynthesis on breast cancer interpretation by both general radiologists and breast imaging specialists. Radiol. Artif. Intell. 6, e230137 (2024).
Kerlikowske, K. et al. Population attributable risk of advanced-stage breast cancer by race and ethnicity. JAMA Oncol. 10, 167–175 (2024).
Sprague, B. L. et al. Assessment of radiologist performance in breast cancer screening using digital breast tomosynthesis vs digital mammography. JAMA Netw. Open 3, e201759 (2020).
Lawson, M. B. et al. Multilevel factors associated with time to biopsy after abnormal screening mammography results by race and ethnicity. JAMA Oncol. 8, 1115–1126 (2022).
Destounis, S. V. Computer-aided detection and second reading utility and implementation in a high-volume breast clinic. Appl. Radiol. 33, 8–12 (2004).
Alabousi, M. et al. Performance of digital breast tomosynthesis, synthetic mammography, and digital mammography in breast cancer screening: a systematic review and meta-analysis. J. Natl Cancer Inst. 113, 680–690 (2020).
Liao, J. M. & Lee, C. I. Strategies for mitigating consequences of federal breast density notifications. JAMA Health Forum 4, e232801 (2023).
Kressin, N. R., Slanetz, P. J. & Gunn, C. M. Ensuring clarity and understandability of the FDA’s breast density notifications. JAMA 329, 121–122 (2023).
Mandelblatt, J. S. et al. Population simulation modeling of disparities in US breast cancer mortality. J. Natl Cancer Inst. Monogr. 2023, 178–187 (2023).
DeSantis, C. E. et al. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J. Clin. 66, 31–42 (2016).
Elmore, J. G. & Lee, C. I. Toward more equitable breast cancer outcomes. JAMA 331, 1896–1897 (2024).
Miglioretti, D. L. et al. Digital breast tomosynthesis: radiologist learning curve. Radiology 291, 34–42 (2019).
Haslam, B., Kim, J. & Soresen, A. G. An AI-based safeguard process to reduce aggressive missed cancers in dense breasts at screening mammography. In Proc. 2023 San Antonio Breast Cancer Symposium 84 PO2-29–04 (AACR, 2024).
Breast Cancer Surveillance Consortium: Evaluating Screening Performance in Practice (National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, 2004).
D’Orsi, C. et al. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System (American College of Radiology, 2013).
Agresti, A. & Coull, B. A. Approximate is better than ‘exact’ for interval estimation of binomial proportions. Am. Stat. 52, 119–126 (1998).